A costly drug frequently used to treat patients with heart disease may offer no greater benefit than standard medications, say Yale researchers. Their study calls into question widespread use of the drug ...
Jun 25, 2015
The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease (CKD) are presented today1 at EHRA EUROPACE - CARDIOSTIM 2015 and published in EP Europace.2
Jun 24, 2015